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ABSTRACT
Objectives Gram-stained urethral smear (GSUS), the
standard point-of-care test for non-gonococcal urethritis
(NGU) is operator dependent and poorly speciﬁc.
The performance of rapid automated urine ﬂow cytometry
(AUFC) of ﬁrst void urine (FVU) white cell counts (UWCC)
for predicting Mycoplasma genitalium and Chlamydia
trachomatis urethral infections was assessed and its
application to asymptomatic infection was evaluated.
Methods Receiver operating characteristic curve
analysis, determining FVU-UWCC threshold for predicting
M. genitalium or C. trachomatis infection was performed
on 208 ‘training’ samples from symptomatic patients and
subsequently validated using 228 additional FVUs
obtained from prospective unselected patients.
Results An optimal diagnostic threshold of
>29 UWC/mL gave sensitivities and speciﬁcities for either
infection of 81.5% (95% CI 65.1% to 91.6%) and
85.8% (79.5% to 90.4%), respectively, compared with
86.8% (71.1% to 95%) and 64.7% (56.9% to 71.7%),
respectively, for GSUS, using the training set samples.
FVU-UWCC demonstrated sensitivities and speciﬁcities of
69.2% (95% CI 48.1% to 84.9%) and 92% (87.2% to
95.2%), respectively, when using validation samples. In
asymptomatic patients where GSUS was not used, AUFC
would have enabled more infections to be detected
compared with clinical considerations only (71.4% vs
28.6%; p=0.03). The correlation between UWCC and
bacterial load was stronger for M. genitalium compared
with C. trachomatis (τ=0.426, p≤0.001 vs τ=0.295,
p=0.022, respectively).
Conclusions AUFC offers improved speciﬁcity over
microscopy for predicting C. trachomatis or M. genitalium
infection. Universal AUFC may enable non-invasive diagnosis
of asymptomatic NGU at the PoC. The degree of urethral
inﬂammation exhibits a stronger association with pathogen
load for M. genitalium compared with C. trachomatis.
INTRODUCTION
Non-gonococcal urethritis (NGU) is diagnosed at the
point of care (PoC) by demonstrating ≥5 poly-
morphonuclear cells per high power ﬁeld (PMN/
HPF) on a Gram-stained urethral smear (GSUS) or
≥10 PMN/HPF from ﬁrst void urine (FVU) sample
sediments.1 These thresholds were derived from
studies predicting urethral infection prior to imple-
mentation of nucleic acid ampliﬁcation testing
(NAAT).2 3 Taking urethral swabs for GSUS is uncom-
fortable for patients.4 Furthermore, microscopy
requires skilled personnel and possesses signiﬁcant
inter-user and intra-user variability,5 6 variable sensi-
tivity and low speciﬁcity for predicting infection.7
Reduced use of microscopy for asymptomatic patients
and the expansion of ‘test and treat’ community-based
sexually transmitted infection screening programmes
for Chlamydia trachomatis infection only reduce the
potential for empirically treating other infective
causes of NGU, such asMycoplasma genitalium.
With a few accurate speciﬁc PoC tests for
common microbiological causes of NGU available,
a rapid, reproducible, cost-effective and accurate
alternative to GSUS is required. Automated urine
ﬂow cytometry (AUFC) of mid-stream urine is
widely adopted by microbiology laboratories for
diagnosing urinary tract infections.8–10 This
method may also be suitable for diagnosing ureth-
ritis if deployable near sexual health clinics, but
this has not been evaluated. We compared the test
performance of GSUS with AUFC of FVU speci-
mens for predicting male urethral infection with
either M. genitalium or C. trachomatis in cases of
symptomatic and asymptomatic NGU.
PATIENTS AND METHODS
Training samples
Samples were collected as part of a previous study
determining the prevalence of aetiological agents of
urethritis.11 Men with symptoms suggestive of
urethritis, prospectively presenting to the genito-
urinary medicine (GUM) clinic at St George’s
Healthcare National Health Service Trust between
28 September 2011 and 15 December 2011, under-
going routine GSUS were eligible for inclusion.
Patients were designated as having either ‘urethritis’
or ‘no urethritis’, as described previously,11 but
excluded if GSUS, NAAT or culture indicated the
presence of Neisseria gonorrhoeae.
Validation samples
All men attending GUM between 31 July 2013 and
15 September 2013. Following sample collection,
only symptomatic patients underwent GSUS
testing, a standard-stratiﬁed care pathway as GSUS
of asymptomatic men reveals a few extra patients
with urethritis.12 All patients underwent AUFC but
were excluded if GSUS or subsequent NAAT or
culture results indicated N. gonorrhoeae presence.
Sample collection and processing
All subjects provided a FVU sample (10–50 mL),
not having voided urine for at least 2 h, 2 mL of
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which was sent for routine C. trachomatis and N. gonorrhoeae
NAAT with BD Viper Qx System (Becton Dickinson, Oxford,
UK). A further 2 mL was sent immediately for AUFC. Following
measurement of residual volume,13 nucleic acids were extracted
from FVU as previously described.11 AUFC of FVU samples was
performed using UF-100i urine ﬂow cytometer (Sysmex, Milton
Keynes, UK). Urinary white cell counts (UWCC) were enumer-
ated per mL of urine.
PCR
Endpoint real-time PCR was performed as described previously2
using probe sets enabling detection of C. trachomatis14 and
M. genitalium.15 Droplet digital PCR (ddPCR) was used to
determine pathogen genome copies per mL of original volume
of FVU collected. Brieﬂy, reaction mixtures of a ﬁnal volume of
20 μL were generated in triplicate, each comprising 10 μL of
ddPCR Master Mix (Bio-Rad), relevant forward and reverse
primers and probe and 8 mL of extracted DNA. Droplets were
generated using each 20 μL reaction and 60 μL of droplet gener-
ation oil using a droplet generator cartridge and droplet gener-
ator (Bio-Rad). Following dispersion, reactions were transferred
into 96-well plates (Eppendorf, Stevenage, UK), heat sealed with
foil and ampliﬁed using the following conditions: 10 min, 95°C;
40 cycles of 15 s at 94°C and 60 s at 60°C and 10 min ﬁnal
inactivation, 98°C. Fluorescence-positive droplets for each
sample were enumerated using QuantaSoft software package
and QX100 instrument (Bio-Rad).
Statistical analysis
Previous work7 suggested that GSUS has 63% speciﬁcity for diag-
nosing C. trachomatis. The training set data for this study were
drawn from a previously reported prevalence-of-infection
study,11 with a sample size of approximately 100 samples from
each of symptomatic non-urethritis and urethritis patients. This
sample set was deemed suitable for the training set as it allowed
an increase in speciﬁcity of UWCC over GSUS of 15% to be
detected with >90% power, (α=0.05), but was too small to
detect changes in sensitivity. The goal of our study was to investi-
gate speciﬁcity improvements. In order to achieve a diagnostic
speciﬁcity and 95% conﬁdence range comparable to those
observed in the training sample analysis, 220 prospective samples
in total were collected for the validation set. Receiver operating
characteristic (ROC) curves of AUFC performance for the predic-
tion of either C. trachomatis or M. genitalium infection were
derived from training set data. Non-parametric cumulative distri-
bution functions for the ROC curves were drawn empirically and
area under the curve was determined. Optimal thresholds of test
positivity were deﬁned using Youden’s index of J.
For the training set, AUFC performance for predicting infec-
tion was compared with GSUS. For the validation set, in two
planned additional analyses we ﬁrst compared UWCC perform-
ance alone against combined use of UWCC with GSUS in order
to explore the impact of retaining GSUS for N. gonorrhoeae
detection in symptomatic patients; second, we focused on
asymptomatic patients where GSUS is not used and where treat-
ment decisions are based on clinical or epidemiological consid-
erations alone and compared those infected with C. trachomatis
or M. genitalium who received treatment with those who would
have received treatment if UWCC were used to aid diagnosis at
the PoC. The validation set was selected to show equivalent spe-
ciﬁcity and also derives information regarding the performance
of the assay in routine use.
In these three analyses, comparisons were made using
McNemar’s test for paired binary data. χ2 tests were used to
detect differences in symptoms and pathogen prevalence
between urethritis and non-urethritis groups within the training
set. Correlations between discrete variables were assessed using
Kendall tau rank correlation coefﬁcient. UWCC and bacterial
load distributions were compared using Mann-Whitney U test.
Statistical analyses were performed using SPSS V.21.
This study was approved by Wandsworth Research Ethics
Committee, London (project number: Q080371).
RESULTS
Training set
FVU specimens were collected from 208 symptomatic patients
(mean age 31 years), 104 with urethritis and 104 with non-
urethritis deﬁned clinically as above. As expected, symptoms of
urethral discharge (69% vs 50%; p≤<0.001) and dysuria (45%
vs 27%; p=0.009) were higher in the urethritis group compared
with non-urethritis group, respectively, but there was no differ-
ence in proportions reporting discomfort (21% vs 27%, respect-
ively; p=0.330).
Overall prevalence of urethral pathogens was 10.5% (n=22)
for M. genitalium and 7.6% (n=16) for C. trachomatis. Both
infections were more prevalent in those diagnosed with ureth-
ritis: M. genitalium was detected in 16.3% (n=17) of urethritis
patients and 4.8% (n=5) of non-urethritis patients (p=0.007).
C. trachomatis was detected in 14.4% (n=15) of urethritis cases
and 1% (n=1) of non-urethritis cases (p≤0.001). No patients
were dually infected with M. genitalium and C. trachomatis.
First void UWCC and GSUS associated with urethral
infection within the training set
Grading of GSUSs demonstrated a difference in distribution
between urethritis groups compared with non-urethritis groups
(p≤0.001) (see ﬁgure 1). As expected, 68% (n=71) of patients
in the urethritis group demonstrated more than 10 PMN/HPF
(median >20 PMN/HPF). Within the non-urethritis group,
96.1% (n=100) of patients possessed less than 10 PMN/HPF
(median <5 PMN/HPF). Four patients in the non-urethritis
group had a microscopy grade of 5–10 PMN/HPF, but were
included in the non-urethritis group on clinical grounds.
UWCC measured by AUFC were increased in the urethritis
group (median 13.7 UWCC/mL) when compared with the non-
urethritis group (median 4 UWCC/mL; p≤0.001). A correlation
between increasing UWCC and GSUS grade was observed
(see ﬁgure 1, τ=0.374, p<0.001). No correlation between the
volume of FVU received and UWCC/mL was observed
(τ=−0.059, p=0.201).
Patients infected with either C. trachomatis or M. genitalium
had increased GSUS grades and median UWCC compared with
non-infected patients (10–20 PMN/HPF vs 1–5 PMN/HPF,
respectively, p<0.001; and 73 UWCC/mL vs 5 UWCC/mL,
respectively, p≤0.001, see ﬁgure 1B).
Assignment of threshold to predict urethral infection
from UWCC
In order to investigate the diagnostic utility of AUFC-UWCC,
an ROC curve was plotted (see online supplementary ﬁgure S3).
Youden’s index analysis gave an indicative threshold for predict-
ing either C. trachomatis or M. genitalium infection of
≥29 UWCC/mL (Youden’s index=0.675). At this threshold,
UWCC had a similar sensitivity to GSUS, 81.5% (95% CI
65.1% to 91.6%) versus 86.8% (95% CI 71.1% to 95%),
respectively, and signiﬁcantly improved speciﬁcity (p<0.001)
and positive predictive value (85.8% (95% CI 79.5% to 90.5%)
vs 64.7% (95%CI 56.9% to 71.7%) respectively; see table 1).
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Validation set
Of 228 patients providing FVU specimens (mean age 32 years),
22% (n=52) were symptomatic and therefore had GSUS, and
9% (n=20) demonstrated >10 PMN/HPF. Overall C. trachoma-
tis and M. genitalium prevalence was 6% (n=14) and 5%
(n=12), respectively. Among symptomatic patients, M. genita-
lium and C. trachomatis prevalence was 8% (n=4) and 17%
(n=9), respectively, and among asymptomatic patients was 3%
(n=5) and 5% (n=8), respectively. No correlation was observed
between FVU volume and UWCC (τ=−0.070, p=0.120).
First void UWCC test performance for prediction of
C. trachomatis or M. genitalium infection
The ≥29 UWCC/mL threshold derived from the training set was
applied to the independent validation set. Sensitivities, speciﬁci-
ties and predictive values are shown in table 2. As expected,
there was a reduction in sensitivity compared with the training
set, although speciﬁcity remained high.
Additional analysis demonstrated that combining UWCC with
GSUS for symptomatic patients resulted in slightly decreased
test speciﬁcity (89.1% vs 92%, p=0.03) when compared with
UWCC alone (see table 2).
In asymptomatic patients (n=176), combining UWCC testing
with epidemiological suspicion of infection and subsequent
treatment improved sensitivity (71.4% vs 28.6%, p=0.031), but
reduced speciﬁcity (90.1% vs 96.3%, p=0.031) when compared
with combining epidemiological suspicion and treatment alone
(see table 2).
Associations between bacterial load and UWCC
There was no difference in FVU bacterial loads between
M. genitalium-infected patients (n=34) and C. trachomatis-infected
patients (n=30), derived from both training and validation sets
(median 256.9 copies/mL cf 194.7 copies/mL, respectively;
p=0.389). The median FVU bacterial load, whether combined or
for each organism, was higher in those with positive UWCC tests
(≥29 UWCC/mL), compared with those with negative UWCC tests
(470 copies/mL cf 36.8 copies/mL, respectively, for M. genitalium
and C. trachomatis combined, p=0.001; 538.7 copies/mL cf
91.1 copies/mL, respectively, for M. genitalium only, p=0.02;
306.9 copies/mL cf 15.4 copies/mL, respectively, for C. trachomatis
only, p=0.005). UWCC were higher in C. trachomatis-infected
patients compared with M. genitalium-infected patients (median,
83.7 UWCC/mL cf 49 UWCC/mL, respectively, p=0.024). UWCC
were positively correlated with M. genitalium bacterial load (see
online supplementary ﬁgure S2A, τ=0.426, p≤0.001) and more
weakly correlated with C. trachomatis bacterial load (see online sup-
plementary ﬁgure S2B, τ=0. 295, p=0.022). Bacterial loads were
not statistically different between GSUS-positive and GSUS-negative
patients, whether asymptomatic or symptomatic (median
305.5 copies/mL cf 139.9 copies/mL, respectively; p=0.58).
DISCUSSION
We observed that AUFC of total white cell count from ﬁrst void
male urine samples, using a small bench-top AUFC system, suitable
for implementation within or near GUM clinic settings, improved
performance for predicting either C. trachomatis orM. genitalium
urethritis in comparison with GSUS, counting neutrophils per
HPF. The automated urine test has the potential to identify
patients with asymptomatic urethritis in a non-invasive manner.
A UWCC threshold of >29/mL applied to symptomatic
patients demonstrated improved speciﬁcity (85.8% vs 64.7%)
and positive predictive value (56.3% vs 35.4%) when compared
with GSUS for predicting either infection. Subsequent testing
Figure 1 Box plots comparing the distributions of ﬁrst void urinary white cell counts (UWCC) per μL in patients with and without urethritis
stratiﬁed by urethral smear grade (A) and C. trachomatis or M. genitalium infection status (B). Training set patients only. The median urinary white
cell count increases as the urethral smear grade increases (A, p≤0.001). UWCC are increased in infected patients with respect to non-infected
patients (B, p≤0.001), regardless of clinical grouping. Negative Gram-stained urethral smear (GSUS): ‘−’ (0 PMN/HPF), ‘−/+’ (1–5 PMN/HPF).
Positive GSUS: ‘+’ (5–10 PMN/HPF), ‘++’ (10–20 PMN/HPF) and ‘+++’ (>20 PMN/HPF). PMN/HPF, polymorphonuclear cells per high power ﬁeld.
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Table 2 Diagnostic performances of UWCC, parallel UWCC/GSUS and stratified diagnosis for the prediction of Chlamydia trachomatis or Mycoplasma genitalium infection using validation samples
Diagnostic performance comparison of UWCC versus UWCC and GSUS performed in parallel using validation samples (n=228)
UWCC* sensitivity
Parallel
UWCC* and
GSUS†
sensitivity
p
Value‡ UWCC* specificity
Parallel
UWCC* and GSUS†
specificity
p
Value‡ UWCC* PPV§
Parallel UWCC
and GSUS
PPV§ UWCC* NPV¶
Parallel UWCC and
GSUS NPV¶
C. trachomatis 71.4%
(42 to 90.4)
78.6%
(48.8 to 94.3)
0.5 N/A N/A 29.4%
(15.7 to 47.6)
26.8%
(14.8 to 43.2)
97.9%
(94.4 to 99.3)
98.3%
(95 to 99.5)
M. genitalium 66.6%
(35.4 to 88.7)
66.60%
(35.4 to 88.7)
0.25 N/A N/A 23.5%
(11.3 to 41.5)
19.5%
(93 to 35.3)
97.9%
(94.4 to 99.3)
97.9%
(94.3 to 99.3)
C. trachomatis
or M. genitalium
69.2%
(48.1 to 84.9)
73%
(51.9 to 87.6)
0.031 92%
(87.2 to 95.2)
89.1%
(83.7 to 92.8)
0.03 53%
(35.3 to 69.8)
46.3%
(30.9 to 60.3)
95.8%
(91.7 to 98)
96.2%
(92.1 to 98.3)
Diagnostic performance comparison of UWCC versus stratified diagnosis using validation samples of asymptomatic patients only (n=176)
UWCC*
sensitivity
Stratified diagnosis**
sensitivity
p
Value‡
UWCC*
specificity
Stratified diagnosis**
specificity
p
Value‡ UWCC* PPV§
Stratified diagnosis
PPV§ UWCC* NPV¶
Stratified approach
NPV¶
C. trachomatis 100%
(40.3% to 100%)
60%
(17% to 92.7%)
0.5 N/A N/A 19.2%
(7.3% to
39.9%)
30%
(8% to 64.6%)
100%
(96.8% to
100%)
98.8%
(95.3% to 99.8%)
M. genitalium 50%
(17.4% to
82.6%)
12.5%
(0.6% to 53.3%)
0.25 N/A N/A 15.4%
(5% to 35.7%)
10%
(0.5% to 45.9%)
97.3%
(92.9% to
99.1%)
95.8%
(91.1% to 98.1%)
C. trachomatis
or
M. genitalium
71.4%
(42% to 90.4%)
28.6%
(9.6% to 58%)
0.031 90.1%
(84.2% to 94%)
96.3%
(91.8% to 98.5%)
<0.01 38.5%
(20.9% to
59.3%)
40%
(13.7% to 72.6%)
97.3%
(92.9% to
99.1%)
93.8%
(88.9% to 96.9%)
*UWCC were defined as positive if the patient’s urine contained >29 White blood cell per mL.
†GSUS testing containing >5 PMN per high power fields (HPFs) over 5 HPFs was examined.
‡p Values represent the results of statistical comparisons of either sensitivity or specificity between the two test methodologies. These were generated using McNemar’s test for paired binary data with the results of C. trachomatis NAAT testing upon BD
Viper System or real-time PCR for M. genitalium as the reference standards.
§Positive predictive value.
¶Negative predictive value.
**Positive stratified diagnosis is defined as patients treated for urethritis due to suggestive clinical history.
GSUS, Gram-stained urethral smear; NAAT, nucleic acid amplification testing; UWCC, urinary white cell counts.
Table 1 Comparison of FVU-UWCC with GSUS test performance for the prediction of either Chlamydia trachomatis or Mycoplasma genitalium infection using training set samples
Test organism
Sensitivity
p Value*
Specificity
p Value*
Positive predictive value Negative predictive value
UWCC† GSUS‡ UWCC† GSUS‡ UWCC† GSUS‡ UWCC† GSUS‡
C. trachomatis 93.7%
(67.7% to 99.6%)
93.7%
(67.7% to 99.6%)
1 N/A N/A 28.3%
(17.1% to 42.5%)
16.1%
(9.6% to 25.5%)
99.3%
(95.8% to 99.9%)
99.1%
(94.5% to 99.9%)
M. genitalium 72.7%
(49.5% to 88.3%)
81.8%
(58.9% to 94%)
0.72 N/A N/A 29%
(18% to 43%)
19.3%
(12.1% to 29.1%)
96%
(91.2% to 98.3%)
96.5%
(90.8% to 98.8%)
C. trachomatis or
M. genitalium
81.5%
(65.1% to 91.6%)
86.8%
(71.1% to 95%)
0.75 85.8%
(79.5% to 90.4%)
64.7%
(56.9 to 71.7%)
<0.001 56.3%
(42.3% to 69.4%)
35.4%
(26% to 46.1%)
95.4%
(90.4% to 97.9%)
95.6%
(89.6% to 98.3%)
*p Values represent the results of statistical comparisons of either sensitivity or specificity between the two test methodologies. These were generated using McNemar’s test for paired binary data with the results of C. trachomatis NAAT testing upon BD
Viper System or real-time PCR for M. genitalium as the reference standards.
†UWCC were defined as positive if the patient’s urine contained >29 White blood cell per mL.
‡GSUS testing containing >5 PMN per high power fields (HPFs) over 5 HPFs was examined.
FVU, first void urine; GSUS, Gram-stained urethral smear; NAAT, nucleic acid amplification testing; UWCC, urinary white cell counts.
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on an independent cohort of men, the majority of whom were
asymptomatic, validated these ﬁndings albeit with a possible
slight but expected reduction in speciﬁcity when UWCC were
combined with GSUS. Our data suggest AUFC represents an
improved PoC test for NGU when compared with microscopy
for predicting urethritis caused by C. trachomatis or M. genita-
lium. However, ﬁrst-line treatments for the two pathogens are
different. In the absence of pathogen-speciﬁc PoC tests, positive
AUFC might best be used as per NGU management guidelines
or as prescreening for using pathogen-speciﬁc PoC tests when
the latter become available.
Associations between PMN leucocyte counts present within
FVU sediment and urethral exudate specimens were ﬁrst
observed by Bowie.2 More recently, microscopic enumeration of
antibody-stained white cells within FVU s was used to study the
association between leucocyte counts and urethral pathogens,16
a technique unsuitable for high throughput use. GSUS has there-
fore remained predominantly in use for diagnosing urethritis on
account of its technical simplicity.
Compared with GSUS, AUFC is simple to perform, rapid
(within a few minutes), offers increased throughput and obviates
the need for invasive urethral swabbing. These features will
improve patient acceptability and potentially allow for triaging
patients into those with and without urethritis on entering the
clinic. Incorporation of further improvements in portability of
ﬂow cytometric devices17 may allow for use in outreach settings,
enabling many more patients to be screened rapidly for ureth-
ritis without the need to attend tertiary healthcare for diagnosis.
Preliminary experiments carried out alongside this study (data
not shown) suggest AUFC is capable of detecting inﬂammation
caused by gonococcal infection. A potential pitfall of replacing
GSUS with AUFC is the loss of PoC diagnosis of N. gonorrhoeae
infection. Observation of intracellular Gram-negative diplococci
upon GSUS possesses sensitivities and speciﬁcities approaching
100% for the diagnosis of gonorrhoea.18 Our results suggest
continuing to deploy GSUS in symptomatic patients alongside
UWCC testing for all patients would retain PoC N. gonorrhoeae
detection while maximising the sensitivity of screening for
C. trachomatis and M. genitalium. Future application of AUFC
in parallel with accurate PoC NAAT testing for gonorrhoea19
should overcome the requirement to retain GSUS.
The sensitivity of GSUS in predicting chlamydial infection in
our study was 93.7% in comparison with 23–63% in previous
studies using NAATs, a difference possibly attributable to
increased sensitivity of the C. trachomatis test platform we used
(BD Viper NAAT)20 when compared with these other
studies.7 21 Our study was not powered to demonstrate a differ-
ence in sensitivity between GSUS and AUFC, although we
believe the beneﬁts in speciﬁcity and the non-invasive nature of
AUFC represent real clinical advantages. The speciﬁcity of
AUFC was likely compromised because we evaluated the accur-
acy of predicting C. trachomatis or M. genitalium infections,
together which usually account for half of NGU causes. All
study samples were screened for Trichomonas vaginalis but a
very low prevalence was observed (data not shown), precluding
its inclusion in this study. Wider population-based studies char-
acterised for larger sets of known22 and candidate23 causes of
NGU may allow further assessment of AUFC test performance.
Asymptomatic patients did not form part of training set samples
and therefore the identiﬁed FVU-UWCC threshold may not be
optimal for identiﬁcation of urethral infection in these patients.
Inclusion of asymptomatic patients within training samples would
have required them to receive unnecessary and potentially uncom-
fortable GSUS testing, which is not recommended by current
guidelines. In this study we applied Youden’s index of J, a method-
ology that applies equal weighting to both sensitivity and speciﬁ-
city when determining the threshold of diagnostic test positivity.
In future, separately developed thresholds for asymptomatic
patients may be necessary for maximum test performance, with
potentially greater weight given to speciﬁcity to prevent inappro-
priate overtreatment of patients.
GSUS and AUFC results did not demonstrate absolute con-
gruence. Four M. genitalium-infected patients and three
C. trachomatis-infected patients were positive by GSUS but
demonstrated <29 UWCC/mL by AUFC. Bacterial loads for
both organisms in these patients were signiﬁcantly lower than
the remaining infected patients, suggesting AUFC may lack sen-
sitivity for predicting infections with a low bacterial burden.
Five patients infected with M. genitalium and two with
C. trachomatis were positive using AUFC but negative by GSUS,
perhaps attributable to technical and observer variations in
GSUS.5 These patients did not demonstrate reduced bacterial
loads. Within validation samples, 13 M. genitalium-positive
patients or C. trachomatis-positive patients did not undergo
microscopy as they were asymptomatic and not required to do
so.12 Three of these patients were asymptomatic contacts of CT
and of these two were UWCC positive.
Associations between bacterial load and UWCC gave insight into
pathogenesis and potential interactions with other infections. First,
we demonstrated C. trachomatis-infected patients possessed signiﬁ-
cantly higher UWCC when compared with M. genitalium-positive
patients. In order to further investigate this ﬁnding, we assessed the
relationship between UWCC and pathogen load. Bacterial load
range of M. genitalium was comparable with other studies24 25 and
there was no difference in pathogen loads between M. genitalium
and C. trachomatis, although this analysis was a secondary outcome
of the study and may not have been sufﬁciently powered to demon-
strate this. However, UWCC were higher in C. trachomatis infec-
tion compared with M. genitalium, suggesting different interactions
or effects of inﬂammation on bacterial replication in the male
genital tract between the two organisms.26 27 Second, C. trachoma-
tis bacterial loads have been shown to be present at 100-fold greater
concentrations than M. genitalium on vaginal swabs, and higher in
vaginal swabs compared with male FVU28 29 samples. Our ﬁndings
of similar loads of C. trachomatis and M. genitalium within male
FVU samples perhaps suggest an altered pathogenesis between male
and female infections. Finally, the observation of a strong propor-
tionate relationship between bacterial burden and inﬂammatory
response observed in this study for M. genitalium supports recent
observations that levels of genital HIV secretion are increased when
M. genitalium burden is high.30
Key messages
▸ Automated ﬂow cytometric analysis of ﬁrst void urine
specimens for the presence of elevated urine white cell
counts (UWCCs) is a practical method for screening patients
for the detection of urethral infection.
▸ This technique is non-invasive, user-independent, rapid and
has enhanced diagnostic speciﬁcity when compared with
gram-stained urethral smear.
▸ Application of this test may allow for and improve the
diagnosis of urethritis in patients who do not report
symptoms.
▸ UWCC are related to pathogen load and may be useful in
ﬁeld and community studies of patients with STIs.
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In conclusion, in the absence of PoC tests capable of detecting
common causes of NGU, and decreased use of GSUS, imple-
mentation of automated UWCC may be an attractive, accurate,
PoC screening test for urethritis and urethral infection in symp-
tomatic and asymptomatic men, enabling immediate syndromic
management for a greater number of patients infected with
either C. trachomatis or M. genitalium.
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